Bio-Thera Solutions, Ltd.'s (SHSE:688177) Last Week's 8.7% Decline Must Have Disappointed Private Companies Who Have a Significant Stake
Bio-Thera Solutions, Ltd.'s (SHSE:688177) Last Week's 8.7% Decline Must Have Disappointed Private Companies Who Have a Significant Stake
Key Insights
主要見解
- The considerable ownership by private companies in Bio-Thera Solutions indicates that they collectively have a greater say in management and business strategy
- The top 2 shareholders own 52% of the company
- 18% of Bio-Thera Solutions is held by insiders
- 私人公司在Bio-Thera Solutions擁有的相當大股權表明它們共同在管理和業務策略上擁有更大的發言權
- 前2名股東擁有該公司的52%。
- Bio-Thera Solutions有18%的股份由內部持有人持有
A look at the shareholders of Bio-Thera Solutions, Ltd. (SHSE:688177) can tell us which group is most powerful. With 51% stake, private companies possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
查看Bio-Thera Solutions有限公司(SHSE:688177)的股東情況,可以告訴我們哪個群體最有權勢。私人公司持有51%的股份,是公司中持股最多的。換句話說,該群體有可能因對公司的投資而獲益最大(或損失最大)
While insiders, who own 18% shares weren't spared from last week's CN¥903m market cap drop, private companies as a group suffered the maximum losses
儘管擁有18%股份的內部人士沒有幸免於上週人民幣90300萬市值的下跌,但私營公司作爲一個整體遭受了最大的損失
Let's delve deeper into each type of owner of Bio-Thera Solutions, beginning with the chart below.
讓我們深入了解Bio-Thera Solutions的每類所有者,首先從下面的圖表開始。
What Does The Institutional Ownership Tell Us About Bio-Thera Solutions?
從機構持股情況可以看出Bio-Thera Solutions的情況如何?
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.
機構投資者通常將自己的回報與常見的指數回報進行比較。因此,他們通常會考慮購買包括在相關基準指數中的較大公司。
Bio-Thera Solutions already has institutions on the share registry. Indeed, they own a respectable stake in the company. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Bio-Thera Solutions' earnings history below. Of course, the future is what really matters.
Bio-Thera Solutions的股份登記表上已經有一些機構。事實上,他們在該公司擁有可觀的股份。 這意味着爲這些機構工作的分析師已經研究過這支股票,而且他們喜歡它。 但和其他人一樣,他們也可能出錯。 如果多家機構同時改變對一支股票的看法,股價可能會迅速下降。 因此,值得看一下Bio-Thera Solutions在下面的收益歷史。 當然,未來才是真正重要的。
Hedge funds don't have many shares in Bio-Thera Solutions. Guangzho Hedy Group Co., Ltd. is currently the largest shareholder, with 39% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 13% and 5.6%, of the shares outstanding, respectively. Shengfeng Li, who is the second-largest shareholder, also happens to hold the title of Chief Executive Officer.
對比特拉方案,對沖基金持有的股份不多。廣州合地集團有限公司目前是最大的股東,持有39%的流通股。同時,第二大和第三大股東分別持有流通股的13%和5.6%。第二大股東李勝峯也恰好擔任首席執行官。
A more detailed study of the shareholder registry showed us that 2 of the top shareholders have a considerable amount of ownership in the company, via their 52% stake.
國瑞科技有合理比例的內部所有權。內部人士在這家市值爲人民幣18億元的公司中擁有4.27億元的股份。這可能表明創始人仍然擁有很多股份。您可以單擊此處查看他們是否一直在買賣。
While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.
雖然研究一個公司的機構持股數據是有意義的,但研究分析師預期增長也是有意義的,因爲很多分析師都有關注這些股票,因此可以很容易地了解預期增長。
Insider Ownership Of Bio-Thera Solutions
Bio-Thera Solutions的內部所有權
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.
在不同國家,內部人員的定義可能會略有不同,但董事會成員始終是內部人員。管理層最終向董事會負責。然而,如果管理人員是創始人或CEO,那麼成爲執行董事會成員也是很常見的。
Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.
大多數人認爲內部所有權是積極的,因爲它可以表示董事會與其他股東的利益相一致。但是,在某些場合下,這個團體的權力過於集中。
Our information suggests that insiders maintain a significant holding in Bio-Thera Solutions, Ltd.. It has a market capitalization of just CN¥9.5b, and insiders have CN¥1.7b worth of shares in their own names. That's quite significant. It is good to see this level of investment. You can check here to see if those insiders have been buying recently.
我們的信息顯示,內部人士在Bio-Thera Solutions, Ltd.持有大量股份。市值僅爲95億元人民幣,內部人士自己名下擁有17億元人民幣的股票。這相當可觀。看到這種投資水平是件好事。您可以在這裏查看這些內部人士最近是否一直在買入。
General Public Ownership
一般大衆所有權
The general public, who are usually individual investors, hold a 13% stake in Bio-Thera Solutions. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.
普通大衆,通常是個體投資者,在Bio-Thera Solutions持有13%的股份。雖然這個群體通常無法左右決策,但確實可以對公司的運營產生實質影響。
Private Equity Ownership
股權投資公司持有8.8%的股份,有能力參與塑造以價值創造爲重點的公司策略。一些投資者可能會因此而受到鼓舞,因爲股權投資公司有時可以鼓勵市場看到公司的價值,從而採取有益的策略。另外,那些持有者可能在將其上市後退出投資。
With an ownership of 5.2%, private equity firms are in a position to play a role in shaping corporate strategy with a focus on value creation. Some investors might be encouraged by this, since private equity are sometimes able to encourage strategies that help the market see the value in the company. Alternatively, those holders might be exiting the investment after taking it public.
作爲業務價值創造的焦點,股權投資公司以5.2%的所有權在塑造企業策略中扮演着重要角色。一些投資者可能會因此感到鼓舞,因爲股權投資有時能夠推動幫助市場認識到公司價值的策略。或者,這些股東們可能在將公司上市後退出了投資。
Private Company Ownership
私有公司的所有權
We can see that Private Companies own 51%, of the shares on issue. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.
雖然考慮到擁有公司的不同團體確實很值得思考,但還有更重要的因素。事實證明,我們發現了一條有關國邦製藥的警告信息,您應該注意。
Next Steps:
下一步:
While it is well worth considering the different groups that own a company, there are other factors that are even more important.
雖然考慮所有擁有一家公司的群體很重要,但還有其他更重要的因素。
I like to dive deeper into how a company has performed in the past. You can access this interactive graph of past earnings, revenue and cash flow, for free.
我喜歡深入了解一家公司過去的表現。您可以免費訪問該互動圖表,了解其過去的盈利、營業收入和現金流。
If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.
如果您像我一樣,可能希望考慮這家公司是否會增長或縮小。幸運的是,您可以查看此免費報告,顯示分析師對其未來的預測。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。